EGFR and glioblastoma: EGFRvIII is the most common mutant that can be detected in up to 30% of GBM patients.3 EGFRvIII is derived from the deletion of exons 2–7, which results in an in‐frame deletion of 267 amino acids from the extracellular domain of wild‐type (wt) EGFR.